Dunlop BW

Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, United States.

2 preprints · 8 papers · ORCID

PreprintPsilocybin

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study

Zarrabi AJ, Mletzko T, Grant G +13

Europe PMC2026
ArticlePsilocybin

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Goodwin GM, Aaronson ST, Alvarez O +28

Europe PMC2026
ArticlePsilocybin

Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.

Perna J, Trop J, Palitsky R +4

Europe PMC2025
ArticlePsilocybin

Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.

Lucido MJ, Dunlop BW

Europe PMC2025
ArticlePsilocybin

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

Goodwin GM, Aaronson ST, Alvarez O +28

Europe PMC2025
ArticleMDMA

The METEMP protocol: Massed exposure therapy enhanced with MDMA for PTSD.

Maples-Keller JL, Dunlop BW, Rothbaum BO

Europe PMC2025
ArticlePsychedelics

Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.

Peacock C, Mascaro JS, Brauer E +7

Europe PMC2024
ArticlePsilocybin

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J +31

Europe PMC2023
ArticlePsilocybin

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.

Dougherty RF, Clarke P, Atli M +10

Europe PMC2025
PreprintPsilocybin

Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing

Dougherty RF, Clarke P, Alti M +10

Europe PMC2022